Sustainable Catalysis
Challenges and Practices for the Pharmaceutical and Fine Chemical Industries
Opens the door to the sustainable production of pharmaceuticals and fine chemicals Driven by both public demand and government regulations, pharmaceutical and fine chemical manufacturers are increasingly seeking to replace stoichiometric reagents used in synthetic transformations with catalytic routes in order to develop greener, safer, and more cost-effective chemical processes. This book supports the discovery, development, and implementation of new catalytic methodologies on a process scale, opening the door to the sustainable production of pharmaceuticals and fine chemicals. Pairing contributions from leading academic and industrial resea…
Mehr
CHF 99.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
Versandkostenfrei
Produktdetails
Weitere Autoren: Dunn, Peter J. (Hrsg.) / Hii, K. K. (Mimi) (Hrsg.) / Krische, Michael J. (Hrsg.)
- ISBN: 978-1-118-35450-6
- EAN: 9781118354506
- Produktnummer: 16368964
- Verlag: Wiley
- Sprache: Englisch
- Erscheinungsjahr: 2013
- Seitenangabe: 440 S.
- Plattform: PDF
- Masse: 22'100 KB
Über den Autor
PETER J. DUNN, PhD, is Global Green Chemistry Lead for Pfizer. Dr. Dunn has played a key role in the development of commercial processes to make several drugs, including Viagra, Emselex, Revatio, and Sampatrilat. K. K. (MIMI) HII, PhD, holds a Readership in Catalysis in the Department of Chemistry at Imperial College London. Her research focuses on the development of sustainable catalytic processes for organic synthesis. MICHAEL J. KRISCHE, PhD, is Director of the Center for Green Chemistry and Catalysis and Robert A. Welch Chair in Science at The University of Texas at Austin. He is the recipient of the Tetrahedron Young Investigator Award, Humboldt Prize, Presidential Green Chemistry Challenge Award, and ACS Elias J. Corey Award. MICHAEL T. WILLIAMS, PhD, is an independent consultant. Previously, he was an executive director at Pfizer and played a key role in the development and commercialization of many drugs, including Zoloft, Viagra, and Relpax.
4 weitere Werke von Michael T. (Hrsg.) Williams:
Bewertungen
Anmelden